Plasma Coagulation Cont., Abnormal

FDA 510(k) K781104 · Ortho Diagnostics, Inc.

Substantially Equivalent

510(k) numberK781104

Submission

Device name
Plasma Coagulation Cont., Abnormal
Applicant
Ortho Diagnostics, Inc.
Mchenry, IL, US
Received
July 3, 1978
Decision date
August 10, 1978
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)

Official FDA 510(k) record

Device classification

Product code
GFO – Activated Partial Thromboplastin
Device class
Class II (moderate risk)
Regulation
21 CFR 864.7925
Specialty
Hematology

Other 510(k)s with product code GFO

510(k)DeviceApplicantDecision
K253957HemosIL Silica Clotting TimeGFO · Special Instrumentation Laboratory (IL) Co.01/09/2026SE
K193556Cryocheck Hex LAGFO · Traditional Precision Biologic10/23/2020SE
K160445HemosIL Silica Clotting TimeGFO · Special Instrumentation Laboratory CO03/16/2016SE
K053111Sta-Cephascreen KitGFO · Traditional Diagnostica Stago, Inc.05/04/2006SE
K060688Hemosil SynthasilGFO · Special Instrumentation Laboratory CO04/13/2006SE
K050221Hemosil Silica Clotting TimeGFO · Traditional Instrumentation Laboratory CO03/30/2005SE
K022021Vital Scientific Aptt, Aptt & Quikcoag ApttGFO · Traditional Vital Scientific N.V.11/01/2002SE
K014028Careside ApttGFO · Traditional Careside Hemotology, Inc.02/08/2002SE
K014008Hemochron Jr. Citrate Aptt CuvetteGFO · Special Itc, Inc.01/24/2002SE
K992712Sigma Diagnostics Alexin LS, Models A1219, A1334GFO · Traditional Sigma Diagnostics, Inc.12/06/1999SE

More from Sigma Diagnostics, Inc.

510(k)DeviceDecision
K802404Ortho Bovine Albumin Solution 30% ProteDCF · Traditional 10/23/1980SE
K801507Antigen Control CellsGOL · Traditional 08/20/1980SE
K800357Bi-Level Assayed Card. Drug Cont., I,IiLAS · Traditional 04/16/1980SE
K800310Ortho Antisera ControlKSF · Traditional 03/05/1980SE
K791791Ortho Antibody Enhancement SolutionKSG · Traditional 10/11/1979SE
K791301Ortho TSH Ria KitJLW · Traditional 09/24/1979SE
K790813Multecon Blood Gas ControlJJS · Traditional 06/28/1979SE
K782166Slide Test for Pregnancy, Gravindex 90JHJ · Traditional 04/04/1979SE
K782063Pregnancy, Sensidex Tube TestJHJ · Traditional 04/04/1979SE
K781638Rubindex*Direct SystemGOK · Traditional 12/20/1978SE

Questions and answers

When was Plasma Coagulation Cont., Abnormal cleared by the FDA?

Plasma Coagulation Cont., Abnormal (K781104) received a 510(k) decision of Substantially Equivalent on August 10, 1978, 38 days after the submission was received.

What is the product code of K781104?

The FDA product code is GFO – Activated Partial Thromboplastin, a Class II (moderate risk) device regulated under 21 CFR 864.7925.